COLD-FX
COLD-FX, licence 80015586: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Cold-FX Extra Strength, Daily Support Cold-FX Extra Strength
- Licence holder
- Bausch & Lomb Inc.
- NPN or DIN-HM
- 80015586
- Status
- Active licence
- Licence date
- 1 February 2010
- Revision date
- 2 December 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 12.0 Année(s) | 1.0 Capsule | 2.0 Tous les jours |
| Adultes | Not specified | 1.0 Capsule | minimum: 2.0 Tous les jours ; maximum: 6.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce the frequency, severity, and duration of cold and flu symptoms by boosting the immune system. Helps to increase production of certain types of cytokines that may signal and activate the immune system in high performing athletes. Helps to increase production of certain types of cytokines involved in the immune response in high performing athletes. Provides further reduction of cold and flu symptoms when taken with a flu shot. Further reduces the frequency, severity and duration of cold and flu symptoms when taken with a flu shot. Clinically proven to reduce the frequency, severity and duration of cold and flu symptoms in individuals over 65 by boosting the immune system. Clinically proven to be safe and efficacious against cold and flu symptoms in individuals over 65. COLD-FX is safe and effective for reducing symptoms associated with acute respiratory tract infections. COLD-FX helps reduce overall symptoms of sore throat, runny nose, sneezing, nasal congestion, malaise, fever, headache, hoarseness, ear-aches and cough. Helps reduce the frequency of cold and flu symptoms when taken daily. Clinically proven to reduce the frequency, severity and duration of cold and flu symptoms in individuals over 65 by boosting the immune system when taken daily. Clinically proven to be safe and efficacious against cold and flu symptoms in individuals over 65 when taken daily. Helps reduce the frequency (number or occurrence), severity and duration of cold and flu symptoms when taken daily.Helps reduce the frequency (number or occurrence) of symptoms associated with upper respiratory tract infections when taken daily.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80015586
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.